• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2023

Year: 2023

Stock News

EnPro: Focusing On Advanced Surface Technologies, Undervalued (NPO)

January 23, 2023 admin 0

SweetBunFactory EnPro Industries, Inc. (NYSE:NPO) serves large customers in very different industries, target markets, and regions, which makes the company’s business model significantly diversified. It is also worth noting that management is undertaking several divestitures […]

Stock News

Buffett Doesn’t Believe In (Or Practice) Market Timing, Nor Should You

January 23, 2023 admin 0

Paul Morigi If you’re familiar with my work then you should’ve worked out that I’m a huge Warren Buffett (Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B)) fan. Whenever I mention or reference Warren, I almost always refer to […]

Stock News

Are Dividend Aristocrat Stocks A Good Investment?

January 23, 2023 admin 0

Yuri_Arcurs/E+ via Getty Images Overview Dividend Aristocrats are stocks in the S&P 500 that have paid increasing dividends for at least 25 consecutive years. In addition to the 25 years of dividend increases, they must […]

Posts navigation

« 1 … 2,462 2,463 2,464 … 4,581 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • Roper Technologies (ROP) Presents At Raymond James Technology Investor Conference
    December 14, 2022 0
  • Lyft: Deep Into Value Territory After The 75% Selloff (NASDAQ:LYFT)
    July 11, 2022 0
  • Factbox-Europe Inc cuts jobs as economy sputters By Reuters
    October 13, 2022 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.